Re: 3M Brand - Dry Powder Inhaler (DPI) Market, page-12

Hi.....

I contacted Adamis via email overnight - the dots are not connected as assumed sorry....

But... in saying this, theirs is in line with the already common Beclomethasone class of Corticosteroids (market plan 2o17/18) which actually highlights even more to us that INVION has a far superior pipeline going on which could totally change the whole field of fight in these diseases.
Also, I see we are going to be using 3M’s Proprietary Pressurised Metered Dose Inhalation (pMDI) technology now & not this DPI model.

I have made it sound like it is the money aspect driving me BUT I have mainly been trying to jump the gun & find out what is happening because my only sister (10 years older with 4 brothers inbetween us) has had Bronchial problems/COPD for many years but visiting her last weekend I could see she is going downhill faster than we thought. She can't use Ventolin or any similar models as for some reason she is allergic to them all (also has an allergic reaction to Penicillin too?) She has a lot of buildup in her lungs & is finding it much more difficult to breathe so am increasingly getting way more concerned & anxious to see INVIONs products get out there asap. Years ago I applied for her to participate in the trials but doesn't work that way.

We believe that Invion is really in groundbreaking territory here especially with trials showing it actually was healing the lungs (unlike other models that slowly damage the lungs instead). I want it out there!

Anyway, I'd like to close this topic heading off now after my post as it isn't relevant at all.

Thanks, Katy